Deciphera Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch DCPH and buy or sell other stocks, ETFs, and their options commission-free!

About DCPH

Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors.

CEO

Ryota Udagawa

CEORyota Udagawa

Employees

—

Employees—

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2003

Founded2003

Employees

—

Employees—

DCPH Key Statistics

Market cap

2.10B

Market cap2.10B

Price-Earnings ratio

-11.58

Price-Earnings ratio-11.58

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$25.61

52 Week high$25.61

52 Week low

$9.90

52 Week low$9.90

People also own

Based on the portfolios of people who own DCPH. This list is generated using Robinhood data, and it’s not a recommendation.